{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:50:01Z","timestamp":1791370201016,"version":"4.3.1"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Probiotic effects are mediated by a network of biochemical transformations and molecular signaling events that influence host physiology through local and systemic mechanisms. This review examines how probiotic microorganisms generate functional metabolites, including short-chain fatty acids, bile acid derivatives, and indole compounds, and how these molecules interact with host receptors and intracellular signaling pathways such as NF-\u03baB, JAK\/STAT, FXR, TGR5, AhR, and inflammasome-mediated signaling. In addition to metabolite-mediated signaling, probiotics may inhibit pathogens through organic acid production, bacteriocins, and quorum-quenching mechanisms, while also contributing to epithelial barrier integrity through modulation of tight-junction proteins and mucosal defenses. These interconnected pathways affect inflammation, metabolic regulation, host\u2013microbe communication, and host defense against pathogens. The review further discusses pharmacomicrobiomic interactions, engineered probiotics, and emerging delivery technologies, highlighting the importance of strain specificity, host context, and microbiome composition in determining therapeutic outcomes. These findings underscore the importance of mechanistic frameworks for the rational development of targeted microbiome-based interventions.<\/jats:p>","DOI":"10.3389\/fnut.2026.1964473","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:55:17Z","timestamp":1791366917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Biochemical and molecular mechanisms of probiotic action: current concepts and emerging therapeutic applications"],"prefix":"10.3389","volume":"13","author":[{"given":"Alexey A.","family":"Churin","sequence":"first","affiliation":[{"name":"Laboratory of Microbial Technologies, Tomsk State University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila O.","family":"Sokolyanskaya","sequence":"additional","affiliation":[{"name":"Laboratory of Microbial Technologies, Tomsk State University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia P.","family":"Lukina","sequence":"additional","affiliation":[{"name":"Laboratory of Microbial Technologies, Tomsk State University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Karnachuk","sequence":"additional","affiliation":[{"name":"Department of Plant Physiology, Biotechnology, and Bioinformatics, Tomsk State University","place":["Tomsk, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"a0000457","DOI":"10.36877\/pmmb.a0000457","article-title":"A current overview of next-generation probiotics and their prospects in health and disease management","volume":"7","author":"Loo","year":"2024","journal-title":"Prog Microbes Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","article-title":"A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae","volume":"70","author":"Zheng","year":"2020","journal-title":"Int J Syst Evol Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: the international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/microorganisms12030430","article-title":"Next-generation probiotics as novel therapeutics for improving human health: current trends and future perspectives","volume":"12","author":"Abouelela","year":"2024","journal-title":"Microorganisms"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41579-026-01311-0","article-title":"Next-generation probiotics: an outlook into current applications and future directions","volume":"24","author":"Kern","year":"2026","journal-title":"Nat Rev Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1272754","DOI":"10.3389\/fmicb.2023.1272754","article-title":"Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics","volume":"14","author":"Spacova","year":"2023","journal-title":"Front Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"103375","DOI":"10.1016\/j.copbio.2025.103375","article-title":"Programmable probiotics as next-generation living therapeutics","volume":"96","author":"Li","year":"2025","journal-title":"Curr Opin Biotechnol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The international scientific Association for Probiotics and Prebiotics consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12672-025-01996-4","article-title":"Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges","volume":"16","author":"Morsli","year":"2025","journal-title":"Discov Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1854998","DOI":"10.3389\/fnut.2026.1854998","article-title":"A polyherbal and probiotic-based immunostimulatory formulation for managing gut dysbiosis in colorectal cancer","volume":"13","author":"Kumar","year":"2026","journal-title":"Front Nutr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-026-00859-9","article-title":"Microbiota-derived metabolite landscapes modulate Fusobacterium fitness and colorectal cancer cell behaviour","author":"Dhiman","year":"2026","journal-title":"Gut Pathog"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"966152","DOI":"10.3389\/fnut.2022.966152","article-title":"Communication in non-communicable diseases and role of immunomodulatory nutraceuticals in their management","volume":"9","author":"Kumar","year":"2022","journal-title":"Front Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1706472","DOI":"10.3389\/fimmu.2025.1706472","article-title":"Gut microbiota metabolites in the immunoregulation of inflammatory bowel disease","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-99-5575-6","volume-title":"Synbiotics in human Health: Biology to Drug Delivery","author":"Dua","year":"2024"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2623359","DOI":"10.1080\/19490976.2026.2623359","article-title":"Precise probiotic therapy: advances, bottlenecks, and the road to microbiome-informed nutrition","volume":"18","author":"Jiang","year":"2026","journal-title":"Gut Microbes"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1201\/9780429057465","volume-title":"Lactic acid bacteria: Microbiological and Functional Aspects","author":"Vinderola","year":"2019"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kope\u0107","year":"2020","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10068-023-01414-x","article-title":"The functional roles of short chain fatty acids as postbiotics in human gut: future perspectives","volume":"33","author":"Ragavan","year":"2023","journal-title":"Food Sci Biotechnol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1152\/ajpendo.00054.2024","article-title":"Understanding how pre- and probiotics affect the gut microbiome and metabolic health","volume":"327","author":"Bock","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"12649","DOI":"10.1038\/s41598-018-30114-4","article-title":"Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome","volume":"8","author":"Nagpal","year":"2018","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/nu12020391","article-title":"Molecules produced by probiotics and intestinal microorganisms with immunomodulatory activity","volume":"12","author":"Delgado","year":"2020","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"650313","DOI":"10.3389\/fphys.2021.650313","article-title":"Use of short-chain fatty acids for the recovery of the intestinal epithelial barrier affected by bacterial toxins","volume":"12","author":"P\u00e9rez-Reytor","year":"2021","journal-title":"Front Physiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40813-022-00264-z","article-title":"Effects of different short-chain fatty acids on gene expression of proteins involved in barrier function in IPEC-J2","volume":"8","author":"Saleri","year":"2022","journal-title":"Porcine Health Manag"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tifs.2023.06.013","article-title":"Targeting gut microbiota and metabolism as the major probiotic mechanism: an evidence-based review","volume":"138","author":"Ma","year":"2023","journal-title":"Trends Food Sci Technol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/nu18030372","article-title":"Prebiotics and gut health: mechanisms, clinical evidence, and future directions","volume":"18","author":"Monteiro","year":"2026","journal-title":"Nutrients"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1513541","DOI":"10.3389\/fmicb.2025.1513541","article-title":"New insights into microbial bile salt hydrolases: from physiological roles to potential applications","volume":"16","author":"Dong","year":"2025","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s44324-025-00066-1","article-title":"Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes","volume":"3","author":"Jyoti","year":"2025","journal-title":"npj Metab Health Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.it.2025.12.008","article-title":"Secondary bile acids as immune and metabolic mediators","volume":"47","author":"Fiorucci","year":"2026","journal-title":"Trends Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"116412","DOI":"10.1016\/j.intimp.2026.116412","article-title":"Probiotic therapeutics: a critical review of mechanisms, clinical efficacy, and the frontier of precision microbiome modulation","volume":"175","author":"Ashaolu","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/biology15090665","article-title":"Probiotics and the human microbiome: classical functions, emerging systemic roles, and future therapeutic frontiers","volume":"15","author":"Zalila-Kolsi","year":"2026","journal-title":"Biology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fmicb.2013.00396","article-title":"Bile resistance mechanisms in Lactobacillus and Bifidobacterium","volume":"4","author":"Ruiz","year":"2013","journal-title":"Front Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1007\/s12602-025-10820-y","article-title":"The science behind probiotics: exploring their mechanisms and therapeutic potential","volume":"18","author":"Entezami","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref35","volume-title":"Probiotics in the Prevention and Management of human Diseases: A scientific Perspective","author":"Dwivedi","year":"2021"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e70151","DOI":"10.1002\/efd2.70151","article-title":"Postbiotic supernatants from psychobiotic strains modulate antioxidant and serotonergic responses","volume":"7","author":"C","year":"2026","journal-title":"eFood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s43393-023-00208-w","article-title":"Advances in probiotics research: mechanisms of action, health benefits, and limitations in applications","volume":"4","author":"Prajapati","year":"2024","journal-title":"Syst Microbiol Biomanuf"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12974-025-03352-3","article-title":"Probiotics alleviate painful diabetic neuropathy by modulating the microbiota\u2013gut\u2013nerve axis in rats","volume":"22","author":"Jiang","year":"2025","journal-title":"J Neuroinflammation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1804560","DOI":"10.3389\/fmicb.2026.1804560","article-title":"Psychobiotics in mental health: insights from human clinical trials via the gut\u2013brain axis","volume":"17","author":"Sisubalan","year":"2026","journal-title":"Front Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1113\/EP093301","article-title":"Psychobiotics and the microbiota\u2013gut\u2013brain axis: emerging paradigms in mental health modulation","volume":"111","author":"Ghahari","year":"2026","journal-title":"Exp Physiol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/nu15071752","article-title":"Dysbiosis of the gut microbiota and kynurenine pathway activity as potential biomarkers in patients with major depressive disorder","volume":"15","author":"Lin","year":"2023","journal-title":"Nutrients"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41467-024-45636-x","article-title":"Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/jpm16020118","article-title":"Contextual regulation of the kynurenine pathway and its relevance for personalized psychiatry","volume":"16","author":"Murata","year":"2026","journal-title":"J Pers Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4161\/gmic.23283","article-title":"New insights into probiotic mechanisms: a harvest from functional and metagenomic studies","volume":"4","author":"Bienenstock","year":"2013","journal-title":"Gut Microbes"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1080\/10408398.2025.2459341","article-title":"Psychobiotics and the gut\u2013brain axis: advances in metabolite quantification and their implications for mental health","volume":"65","author":"Kyei-Baffour","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3390\/nu17132139","article-title":"Psychobiotics in depression: sources, metabolites, and treatment\u2014a systematic review","volume":"17","author":"\u015aliwka","year":"2025","journal-title":"Nutrients"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.arr.2015.01.003","article-title":"DAMPs as mediators of sterile inflammation in aging-related pathologies","volume":"24","author":"Feldman","year":"2015","journal-title":"Ageing Res Rev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1249098","DOI":"10.3389\/fimmu.2023.1249098","article-title":"Role of toll-like receptors and nod-like receptors in acute lung infection","volume":"14","author":"Le","year":"2023","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/biom15111609","article-title":"Lactobacilli-derived microbe-associated molecular patterns in host immune modulation","volume":"15","author":"Furnari","year":"2025","journal-title":"Biomolecules"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"13475","DOI":"10.3390\/ijms222413475","article-title":"Molecular and cellular mechanisms influenced by postbiotics","volume":"22","author":"Jastrz\u0105b","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41522-025-00903-7","article-title":"Probiotic bacteria Bifidobacterium bifidum upregulation of intestinal epithelial tight junction barrier is mediated by TLR-2\/TLR-6 receptor complex activation of occludin gene","volume":"12","author":"Abdulqadir","year":"2026","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nri1630","article-title":"Negative regulation of toll-like receptor-mediated immune responses","volume":"5","author":"Liew","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"106081","DOI":"10.1016\/j.bbi.2025.106081","article-title":"Chronic ethanol exposure induces hippocampal neuroinflammation and neuronal damage via the astrocytic RUNX1\/TOLLIP\/TLR3 pathway","volume":"130","author":"Shen","year":"2025","journal-title":"Brain Behav Immun"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00284-026-04992-1","article-title":"Gut microbiota and autoimmune diseases: the therapeutic potential of probiotics","volume":"83","author":"Domaga\u0142a","year":"2026","journal-title":"Curr Microbiol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12865-022-00484-6","article-title":"The effects of the probiotic cocktail on modulation of the NF-\u03baB and JAK\/STAT signaling pathways involved in the inflammatory response in bowel disease model","volume":"23","author":"Aghamohammad","year":"2022","journal-title":"BMC Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.3390\/ijms25115723","article-title":"Probiotics in wound healing","volume":"25","author":"B\u0103d\u0103lu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.12968\/jowc.2023.0302","article-title":"Effect of oral multispecies probiotic on wound healing, periodontitis and quality of life in patients with diabetes","volume":"33","author":"Stuermer","year":"2024","journal-title":"J Wound Care"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1017\/S0007114508930373","article-title":"In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis","volume":"100","author":"Fitzpatrick","year":"2008","journal-title":"Br J Nutr"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/1348-0421.12752","article-title":"Amelioration of colitis in mice by Leuconostoc lactis EJ-1 by M1 to M2 macrophage polarization","volume":"64","author":"Jang","year":"2020","journal-title":"Microbiol Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1002\/iid3.1045","article-title":"Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis","volume":"11","author":"Guo","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/jpm13101487","article-title":"Probiotics and probiotic-like agents against chemotherapy-induced intestinal mucositis: a narrative review","volume":"13","author":"L\u00f3pez-G\u00f3mez","year":"2023","journal-title":"J Pers Med."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e13264","DOI":"10.1111\/cmi.13264","article-title":"Distinctive probiotic features share common TLR2-dependent signalling in intestinal epithelial cells","volume":"23","author":"Pavelj\u0161ek","year":"2021","journal-title":"Cell Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tifs.2019.11.022","article-title":"Interactions between probiotics and pathogenic microorganisms in hosts and foods: a review","volume":"95","author":"Khaneghah","year":"2020","journal-title":"Trends Food Sci Technol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1128\/AEM.66.5.2001-2005.2000","article-title":"Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane","volume":"66","author":"Alakomi","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins\u2014a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1042\/BST20180165","article-title":"Engineering quorum quenching enzymes: Progress and perspectives","volume":"47","author":"Murugayah","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/14787210.2020.1794815","article-title":"Quorum quenching enzymes and their effects on virulence, biofilm, and microbiomes: a review of recent advances","volume":"18","author":"Sikdar","year":"2020","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/femsre\/fuv038","article-title":"Quorum quenching: role in nature and applied developments","volume":"40","author":"Grandcl\u00e9ment","year":"2016","journal-title":"FEMS Microbiol Rev"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/1541-4337.12676","article-title":"Cell-envelope proteinases from lactic acid bacteria: biochemical features and biotechnological applications","volume":"20","author":"Ji","year":"2021","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.bbamem.2015.03.007","article-title":"Increased membrane surface positive charge and altered membrane fluidity leads to cationic antimicrobial peptide resistance in Enterococcus faecalis","volume":"1848","author":"Kumariya","year":"2015","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.copbio.2020.01.005","article-title":"Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea","volume":"61","author":"Mekonnen","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/10408398.2022.2072705","article-title":"Probiotics: insights and new opportunities for Clostridioides difficile intervention","volume":"49","author":"Pal","year":"2023","journal-title":"Crit Rev Microbiol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/03007995.2023.2205333","article-title":"Probiotics for primary prevention of Clostridioides difficile infection: revisiting the evidence","volume":"39","author":"Fajnzylber","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-031-42108-2_6","volume-title":"Updates on Clostridioides difficile in Europe: Advances in Microbiology, Infectious Diseases and public Health","author":"Vald\u00e9s-Varela","year":"2024"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5114\/pg.2025.148486","article-title":"Probiotic use reduces the incidence of antibiotic-associated diarrhea among adult patients: a meta-analysis","volume":"20","author":"Wanyama","year":"2025","journal-title":"Prz Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.lanepe.2024.101151","article-title":"Comparative effectiveness of different therapies for Clostridioides difficile infection in adults: a systematic review and network meta-analysis of randomized controlled trials","volume":"49","author":"Bedn\u00e1rik","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tim.2017.10.005","article-title":"Quorum-sensing systems as targets for antivirulence therapy","volume":"26","author":"Defoirdt","year":"2018","journal-title":"Trends Microbiol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1128\/AEM.02378-13","article-title":"Resistance to quorum-quenching compounds","volume":"79","author":"Garc\u00eda-Contreras","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/MMBR.00046-12","article-title":"Exploiting quorum sensing to confuse bacterial pathogens","volume":"77","author":"LaSarre","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/jsfa.70168","article-title":"Probiotics as modulators of intestinal barrier integrity and immune homeostasis: a comprehensive review","volume":"106","author":"Mercado-Monroy","year":"2026","journal-title":"J Sci Food Agric"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"G807","DOI":"10.1152\/ajpgi.00243.2009","article-title":"Probiotic bacteria and intestinal epithelial barrier function","volume":"298","author":"Ohland","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1671152","DOI":"10.3389\/fcell.2025.1671152","article-title":"Probiotics and the intestinal tight junction barrier function","volume":"13","author":"Ferris","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"107785","DOI":"10.1016\/j.micpath.2025.107785","article-title":"Protective mechanism of Bifidobacterium on intestinal mucosal barrier in sepsis","volume":"206","author":"Zhang","year":"2025","journal-title":"Microb Pathog"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives","volume":"29","author":"Roy","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1875044301205010055","article-title":"Enhancement of epithelial barrier function by probiotics","volume":"5","author":"Madsen","year":"2012","journal-title":"J Epithel Biol Pharmacol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/fft2.70168","article-title":"Engineered probiotics: the next-generation therapeutics to combat antibiotic-resistant bacterial infections","volume":"7","author":"Singh","year":"2026","journal-title":"Food Front"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat Commun"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I study of SYNB1891, an engineered Escherichia coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1485546","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44368-026-00019-w","article-title":"Engineering microbial metabolites to modulate tumor immunity and advance cancer immunotherapy","volume":"3","author":"Chigozie","year":"2026","journal-title":"Discov Immunol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"105218","DOI":"10.1016\/j.critrevonc.2026.105218","article-title":"Integrating STING activation with programmed death-ligand 1 inhibition: novel approaches for cancer treatment","volume":"221","author":"Khorramdelazad","year":"2026","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"931176","DOI":"10.3389\/fimmu.2022.931176","article-title":"The absence of STING ameliorates non-alcoholic fatty liver disease and reforms gut bacterial community","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1039\/D4MD00477A","article-title":"Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis management via modulation of the cGAS-STING pathway","volume":"15","author":"Saad","year":"2024","journal-title":"RSC Med Chem"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2478\/am-2025-0013","article-title":"Understanding probiotics, prebiotics, synbiotics, and postbiotics: a comprehensive review of the newest definitions, selected strains and products","volume":"64","author":"Wo\u017aniak","year":"2025","journal-title":"Post Mikrobiol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1692365","DOI":"10.3389\/fimmu.2025.1692365","article-title":"Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest continues","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/microorganisms12020238","article-title":"The potential harmful effects of genetically engineered microorganisms on the intestinal microbiome and public health","volume":"12","author":"Lerner","year":"2024","journal-title":"Microorganisms."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"102727","DOI":"10.1016\/j.mib.2026.102727","article-title":"Advances in biocontainment strategies of engineered microbes for use in humans","volume":"91","author":"Fuerte-Stone","year":"2026","journal-title":"Curr Opin Microbiol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12934-026-02997-w","article-title":"From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics","volume":"25","author":"Di Pierro","year":"2026","journal-title":"Microb Cell Factories"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","article-title":"Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements","volume":"15","author":"Hayashi","year":"2024","journal-title":"Nat Commun"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/futurepharmacol6020030","article-title":"Exploring microbiota-based interventions for different system diseases: adjuncts to targeted pharmaceutical therapies","volume":"6","author":"Fermin Olivares","year":"2026","journal-title":"Future Pharmacol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","article-title":"Bioaccumulation of therapeutic drugs by human gut bacteria","volume":"597","author":"Kl\u00fcnemann","year":"2021","journal-title":"Nature"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s12602-025-10462-0","article-title":"Synergistic interactions between probiotics and anticancer drugs: mechanisms, benefits, and challenges","volume":"17","author":"Pezeshki","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1521-6918(03)00055-6","article-title":"Basic aspects and pharmacology of probiotics: an overview","volume":"17","author":"Marteau","year":"2003","journal-title":"Pharmacol Res"},{"key":"ref108","first-page":"357","volume-title":"Enhancing Autonomous and Adaptive Systems with AI and IoT","author":"Kumar","year":"2026"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.scib.2025.12.046","article-title":"Calenduloside E produced by Bifidobacterium animalis B960 increases glibenclamide efficacy and alleviates drug-induced adverse effects in a type 2 diabetes model","volume":"71","author":"Shen","year":"2025","journal-title":"Sci Bull"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e13424","DOI":"10.1111\/1541-4337.13424","article-title":"A comprehensive review of the characterization, host interactions, and stabilization advancements on probiotics: addressing the challenges in functional food diversification","volume":"23","author":"Fentie","year":"2024","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S636168","article-title":"Probiotic carriers for tumor-targeted therapy: applications and challenges","volume":"21","author":"Hao","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s12602-025-10573-8","article-title":"Harnessing the microbiome: CRISPR-based gene editing and antimicrobial peptides in combating antibiotic resistance and cancer","volume":"17","author":"Amen","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"470","DOI":"10.20892\/j.issn.2095-3941.2025.0511","article-title":"Postbiotics: emerging bioactive agents in cancer therapy","volume":"23","author":"Li","year":"2026","journal-title":"Cancer Biol Med"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e17989","DOI":"10.1002\/advs.202517989","article-title":"Oncolytic probiotics with molecular pili for solid tumor therapy","volume":"13","author":"Ge","year":"2026","journal-title":"Adv Sci"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3390\/foods15122079","article-title":"Probiotic bacteria in stimulating human physiological responses: metabolic function and overall health","volume":"15","author":"Chong","year":"2026","journal-title":"Foods"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12275-024-00124-1","article-title":"Application of microbiome-based therapies in chronic respiratory diseases","volume":"62","author":"Lee","year":"2024","journal-title":"J Microbiol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1617546","DOI":"10.3389\/fphar.2025.1617546","article-title":"Gut-lung axis in allergic asthma: microbiota-driven immune dysregulation and therapeutic strategies","volume":"16","author":"Lv","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"151408","DOI":"10.1016\/j.semnephrol.2023.151408","article-title":"Gut microbiota-targeted interventions in the management of chronic kidney disease","volume":"43","author":"Sumida","year":"2023","journal-title":"Semin Nephrol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e70205","DOI":"10.1002\/fft2.70205","article-title":"Postbiotics in functional foods: microbial derivatives shaping health, immunity and next-generation nutrition","volume":"7","author":"Mafe","year":"2026","journal-title":"Food Front"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1740322","DOI":"10.3389\/fcimb.2025.1740322","article-title":"Gut microbiota modulation in gastrointestinal disorders: current evidence and therapeutic perspectives","volume":"15","author":"Zhang","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1713426","DOI":"10.3389\/fimmu.2025.1713426","article-title":"Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives\u2014a comprehensive review","volume":"16","author":"El-Saadony","year":"2025","journal-title":"Front Immunol"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"188494","DOI":"10.1016\/j.bbcan.2020.188494","article-title":"Effect of probiotics and gut microbiota on anti-cancer drugs: mechanistic perspectives","volume":"1875","author":"Badgeley","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3390\/ijms27052218","article-title":"From probiotics to postbiotics\u2014an update on their biotherapeutic potential and the emerging strategies in human health","volume":"27","author":"Maftei","year":"2026","journal-title":"Int J Mol Sci"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.biotechadv.2024.108336","article-title":"Next generation probiotics: engineering live biotherapeutics","volume":"72","author":"Murali","year":"2024","journal-title":"Biotechnol Adv"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"151123","DOI":"10.1016\/j.ijbiomac.2026.151123","article-title":"Engineering bioavailability: polysaccharide-protein-lipid delivery platforms for postbiotic therapeutics in gastrointestinal and systemic disorders","volume":"351","author":"Leghari","year":"2026","journal-title":"Int J Biol Macromol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"118182","DOI":"10.1016\/j.biopha.2025.118182","article-title":"The bile acid\u2013gut microbiota axis: a central hub for physiological regulation and a novel therapeutic target for metabolic diseases","volume":"188","author":"Zhao","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1039\/D2FO01252A","article-title":"Targeting gut microbial bile salt hydrolase by diet supplements: new insights into dietary modulation of human health","volume":"13","author":"Yang","year":"2022","journal-title":"Food Funct"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1964473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:55:20Z","timestamp":1791366920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1964473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":128,"alternative-id":["10.3389\/fnut.2026.1964473"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1964473","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"1964473"}}